WEC
Winslow Evans & Crocker’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $98K | Buy |
1,885
+185
| +11% | +$9.62K | 0.02% | 441 |
|
|
2020
Q3 | $74K | Sell |
1,700
-1,700
| -50% | -$74K | 0.02% | 401 |
|
|
2020
Q2 | $146K | Hold |
3,400
| – | – | 0.04% | 302 |
|
|
2020
Q1 | $124K | Hold |
3,400
| – | – | 0.04% | 299 |
|
|
2019
Q4 | $156K | Hold |
3,400
| – | – | 0.04% | 325 |
|
|
2019
Q3 | $122K | Hold |
3,400
| – | – | 0.03% | 356 |
|
|
2019
Q2 | $136K | Hold |
3,400
| – | – | 0.04% | 341 |
|
|
2019
Q1 | $142K | Hold |
3,400
| – | – | 0.04% | 324 |
|
|
2018
Q4 | $126K | Hold |
3,400
| – | – | 0.04% | 323 |
|
|
2018
Q3 | $166K | Hold |
3,400
| – | – | 0.05% | 286 |
|
|
2018
Q2 | $148K | Hold |
3,400
| – | – | 0.05% | 305 |
|
|
2018
Q1 | $142K | Hold |
3,400
| – | – | 0.05% | 303 |
|
|
2017
Q4 | $148K | Hold |
3,400
| – | – | 0.05% | 305 |
|
|
2017
Q3 | $145K | Sell |
3,400
-1,430
| -30% | -$60.8K | 0.05% | 297 |
|
|
2017
Q2 | $208K | Hold |
4,830
| – | – | 0.06% | 310 |
|
|
2017
Q1 | $202K | Hold |
4,830
| – | – | 0.06% | 294 |
|
|
2016
Q4 | $189K | Hold |
4,830
| – | – | 0.06% | 299 |
|
|
2016
Q3 | $213K | Hold |
4,830
| – | – | 0.06% | 293 |
|
|
2016
Q2 | $202K | Hold |
4,830
| – | – | 0.06% | 279 |
|
|
2016
Q1 | $194K | Hold |
4,830
| – | – | 0.06% | 275 |
|
|
2015
Q4 | $247K | Hold |
4,830
| – | – | 0.07% | 263 |
|
|
2015
Q3 | $227K | Buy |
4,830
+2,454
| +103% | +$115K | 0.07% | 254 |
|
|
2015
Q2 | $296K | Hold |
2,376
| – | – | 0.08% | 237 |
|
|
2015
Q1 | $293K | Buy |
2,376
+196
| +9% | +$24.2K | 0.08% | 244 |
|
|
2014
Q4 | $235K | Hold |
2,180
| – | – | 0.07% | 265 |
|
|
2014
Q3 | $231K | Buy |
2,180
+1,700
| +354% | +$180K | 0.07% | 284 |
|
|
2014
Q2 | $49.8K | Buy |
+480
| New | +$49.8K | 0.02% | 501 |
|